China
· Delayed Price · Currency is CNY KPC Pharmaceuticals,Inc. Company Description
KPC Pharmaceuticals,Inc., a pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs in the People’s Republic of China and internationally.
It offers artemisia annua series, panax notoginseng, gastrodia, specialty herbal, fine Chinese, and classic prescription for bones and joint, antibiotic, immunosuppressive, and others.
The company provides medicine and food, skin care, oral care, private care, and time-honored food series; and other products, such as oral medication and injections.
It markets artemisinin antimalarials, generic drugs, and medical apparatus. The company was formerly known as Kunming Pharmaceutical Corporation and changed its name to KPC Pharmaceuticals, Inc. in April 2015.
The company was founded in 1951 and is based in Kunming, the People’s Republic of China.
| Country | China |
| Founded | 1951 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 5,275 |
| CEO | Wei Yan |
Contact Details
Address: No.166 Keyi Road Kunming, 650106 China | |
| Phone | 86 871 6831 9868 |
| Website | kpc.com.cn |
Stock Details
| Ticker Symbol | 600422 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE0000015P8 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Sun Zhi Qiang | Financial Director |
| Zhang Mengxun | Board Secretary and General Counsel |
| JunFeng Liu | Senior Vice President |
| Li Meng | Executive Vice President |
| Wei Yan | President and Vice Chairman |